HIGHLIGHTS
- who: Vasileios Vardas et al. from the Laboratory of Biochemistry/Metastatic Signaling, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, Patras, Greece have published the research work: Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of /2023/
- what: This study aimed to investigate the expression of PD-L1 CTLA-4 GLU and VIM in CTCs of TNBC patients. The primary endpoint of the study was the identification . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.